Page last updated: 2024-09-03

gefitinib and Dermatitis, Contact, Phototoxic

gefitinib has been researched along with Dermatitis, Contact, Phototoxic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Burke, NS; Dassanayake, S; Mealey, KL	1

Other Studies

1 other study(ies) available for gefitinib and Dermatitis, Contact, Phototoxic

Article	Year
Tyrosine kinase inhibitors enhance ciprofloxacin-induced phototoxicity by inhibiting ABCG2. Oncology, 2014, Volume: 87, Issue:6 Topics: Anti-Bacterial Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzamides; Blotting, Western; Ciprofloxacin; Dermatitis, Phototoxic; Drug Synergism; Flow Cytometry; Gefitinib; Gene Expression Regulation; HEK293 Cells; Humans; Imatinib Mesylate; Neoplasm Proteins; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Quinazolines; Risk Factors	2014

Article

Year

Tyrosine kinase inhibitors enhance ciprofloxacin-induced phototoxicity by inhibiting ABCG2.

Oncology, 2014, Volume: 87, Issue:6

Topics: Anti-Bacterial Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzamides; Blotting, Western; Ciprofloxacin; Dermatitis, Phototoxic; Drug Synergism; Flow Cytometry; Gefitinib; Gene Expression Regulation; HEK293 Cells; Humans; Imatinib Mesylate; Neoplasm Proteins; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Quinazolines; Risk Factors

2014